Marwan Sabbagh - Mar 14, 2022 Form 4 Insider Report for Cortexyme, Inc. (QNCX)

Role
Director
Signature
/s/ Caryn McDowell, Attorney-in-Fact for Marwan Sabbagh
Stock symbol
QNCX
Transactions as of
Mar 14, 2022
Transactions value $
$0
Form type
4
Date filed
3/16/2022, 06:33 PM
Next filing
Aug 24, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction QNCX Stock Option (right to buy) Award $0 +22.1K $0.00 22.1K Mar 14, 2022 Common Stock 22.1K $4.79 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option shall vest in equal annual installments over the three-year period following the grant date of March 14, 2022.